A lthough the improvement of treatment modalities in neonatal intensive care units (NICUs) has increased the survival rates of extremely low-birthweight (ELBW) infants (< 1000 g), severe intraventricular hemorrhage (IVH) and subsequent posthemorrhagic hydrocephalus (PHH) still represent serious complications of premature birth and major causes of neurodevelopmental impairment.
Introduction of percutaneous-tunneled transfontanellar external ventricular drainage in the management of hydrocephalus in extremely low-birth-weight infants tricular dilation has become progressive, early treatment of the hydrocephalus may reduce the period of brain injury, with a consequent reasonable improvement in the final global outcome. 16 Extremely low-birth-weight infants represent a subgroup of hydrocephalic patients in whom early surgical treatment of the hydrocephalus represents a challenge for many reasons: thinness of skin, risk of skin ulceration, CSF fistula, infection, and pulmonary hemodynamic instability together with the inability to move the infant out of the incubator. Concern about these frequent complications 12 of standard treatments can delay surgery, and the infant's weight increase in this period of delay will reduce the operative risk. Indeed, from a surgical point of view, operating on an infant weighing 950 g is incomparably easier and safer than performing the same operation on the same patient when he or she weighs 500 g (both cases are considered ELBW) since the lower the weight, the fewer the feasible surgical options and the higher the risks.
A possible final treatment for hydrocephalus in children is the implantation of a permanent CSF shunt. 7 In ELBW infants, such invasive surgery is impractical because of the aforementioned risks and the presence of blood and clots within the ventricles, which must be removed before shunt implantation. To achieve the goal of implantation, several standardized techniques have been proposed over time: repeated transfontanellar ventricular puncture and intermittent lumbar puncture, standard external ventricular drainage, Ommaya reservoir implantation, and ventriculosubgaleal shunt implantation. None of these procedures can be considered without risks even in full-term babies, and operating on such small patients would increase the probability of serious complications.
We introduced and modified in our treatment protocol for PHH an already described technique 9 usually reserved for infants under 1000 g, which helps to achieve early control of the hydrocephalus and to gain time while waiting for the weight and general condition of these small patients to allow safer surgical implantation of a permanent shunt.
Methods
In the last 3 years (first case in December 2012, last case in May 2015), we have treated 10 cases of PHH in ELBW infants (5 cases < 700 g, range for all cases 550-1000 g) by implanting a percutaneous-tunneled, transfontanellar (PTT) external ventricular drain (EVD) via a purely percutaneous technique at bedside, as the first measure in a stepwise approach (Fig. 1) .
surgical technique
All procedures were performed by the pediatric neurosurgeon in 3 different NICUs located in the same regional area of Italy (Emilia-Romagna; 4,500,000 inhabitants) and under strict aseptic conditions; antibiotic prophylaxis with vancomycin and piperacillin/tazobactam was administered perioperatively. The patient, under general anesthesia, was supine with the head slightly elevated. The entry site for the ventricular drain (right lateral edge of the bregmatic fontanel) and the catheter's exit site (temporal region) were marked, and the surgical field was draped.
The entry site was punctured with an intravenous catheter (14-gauge, 2.1 × 45 mm, BD Insyte) and subcutaneously tunneled from the fontanel edge to the temporal exit site, leaving the sleeve in place. A blunt, multiple side-hole catheter made of polyvinyl chloride (4-Fr, 2 × 400 mm, Unomedical-Convatec) was threaded into the sleeve distally to proximally (Fig. 2A) ; then the sleeve was removed, leaving the drain inside the subcutaneous tunnel. With the needle tip, a small perforation of the dura mater (smaller than the catheter diameter) was made at the entry site. Then the smoothed distal extremity of the drain was gently inserted through the dura and fed into the ventricle under ultrasonographic control (ipsilateral mastoid view; Fig. 3 ). Tight adhesion of the catheter to the dural ring was achieved to minimize the risk of CSF leakage. Once the drain was properly placed, passive dripping of CSF was observed from its external end. Afterward, the external end was slid outward through the subcutaneous tunnel, and the drain was fixed with Steri-Strips at the exit site, while the entry site and tunnel were sealed with fibrin glue and covered with soft sterile gauze ( Fig.  2B-D) . To allow repeated CFS tapping, the external end of the PTTEVD was closed with a sterile plug device and protected with sterile bandages.
results
The characteristics of the patients are listed in Table 1 . The mean patient weight was 750 g, the average duration of the procedure was 7 minutes, and there was no blood loss.
In all cases but 2, there was no history of sepsis. In Case 2, the PTTEVD was implanted in a patient who weighed more than the other patients, obtaining resolution of the infection and treating the hydrocephalus in the same way as with a traditional EVD, while maintaining the advantages of a quick, minimally invasive, bedside procedure. The patient in Case 5 died of Streptococcus sepsis, a systemic infection existing prior to PTTEVD placement and remaining unresolved (sterile CSF samples). After PTTEVD placement, twice-daily removal of CSF (approximately 5 ml until the fontanellar tension became normal) was started and performed by the neonatologist. Additionally, brain ultrasonography scans were obtained by placing properly sterilized devices on the probe and were evaluated daily, and in cases of ventricular enlargement, the amount of CSF removal was adjusted. Each CSF sample was submitted to bacterial culture and cytochemical evaluation. Antibiotics were administered during the entire drainage period. Whenever possible, efforts to maintain asepsis in the daily management of the child were made.
The PTTEVD remained in place for an average of 24 days; no infection was detected on serial CSF cultures except in 1 case in which, on the day after abdominal surgery with ileostomy, an Enterococcus was detected in the CSF sample. Consequently, the patient was immediately started on a 7-day cycle of daily intrathecal vancomycin (2 mg at 1 mg/ml concentration, taking into account the extra infusion volume of the PTTEVD). Bacteria in the CSF were eliminated, and the CSF remained sterile for the remaining period of hospitalization.
In the patient in Case 4, a single CSF leakage episode occurred as a result of insufficient CSF withdrawal: oncedaily removal of CSF was scheduled, CSF leakage occurred, and after resuming twice-daily CSF removal no more leaks were observed.
Once a patient reached 1 kg of weight, when necessary (progressive ventricular dilation after suspension of CSF withdrawal), a ventriculoperitoneal shunt (occipital entry site) was implanted and the PTTEVD was removed.
According to available data on the patients receiving shunts, the follow-up period ranged from 7 to 34 months. In 1 case, after 8 months, the shunt was revised because of intracranial catheter occlusion, but no shunt infection was observed.
Discussion
The treatment of PHH in ELWB infants still represents a challenge for the pediatric neurosurgeon, particularly when the patient weighs far less than 1000 g. In these cases, the advantages of early treatment in terms of neurological outcome do not always outweigh the surgical risks, especially considering the great difference in the surgical risk before patient weight increases. In fact, before the introduction of our technique, our experience in managing such extreme cases led us to try to postpone treatment, not only because of the risks of CSF leakage, skin dehiscence, infection, and overdrainage, but also because of the global and anesthesiology risks related to surgery on delicate and hemodynamically unstable patients.
The optimal timing of intervention has not yet been established; thus, we decided to place the PTTEVD when the ventricular indexes were significantly above the 95th percentile reference intervals 4, 5, 14 without waiting for the appearance of signs and symptoms of raised intracranial pressure. 6 In all cases, to initiate neurosurgical treatment, in addition to the progressive ultrasonography findings (ventricular index > 95th percentile), evidence of progressive growth of the head circumference was considered necessary; diastasis of the cranial sutures, dilated scalp veins, and bulging of the anterior fontanel have never occurred. As a matter of fact, the early treatment of hydrocephalus in preterm infants with PHH and no initial parenchymal injuries is associated with reduced rates of cognitive, communicative, and social disabilities, although in our series motor function and cerebral palsy rates had not shown any modification. 3, 6 Thus, our stepwise approach might allow surgeons to accelerate the timing of intervention even in babies with temporary contraindications to neurosurgical approaches.
Although the placement of a permanent CSF drain represents the definitive therapeutic option for PHH, it should not be considered a first-line treatment in ELBW infants given its high risks of obstruction, infection, and skin ulceration. 18, 19 Thus, alternative protocols are needed to manage the progressive ventricular dilation while waiting for improved medical conditions before placing a permanent CSF drain.
Positioning a subcutaneous ventricular reservoir is considered a safe and effective procedure in preterm infants; 5 however, the associated risks in ELBW infants (for example, skin ulceration over the reservoir area) are not negligible and should be taken into account.
As an alternative, positioning a ventriculosubgaleal shunt represents a valid therapeutic option for PHH in infants, and many series have reported the routine use of this option even in ELBW infants, with a variable occurrence of complications. 10, 13, 17, 21 However, our experience with this technique suggests that if a baby weighs less than 1 kg, the thinness of the skin can become an issue, especially if the consequent subgaleal CSF buildup increases significantly, with stretching of the tissues and the risk of CSF leakage. Moreover, the implantation of a ventriculosubgaleal shunt requires a longer surgical time and a wide skin incision, as compared with those needed in the pure percutaneous technique of PTTEVD placement (with an average 7-minute procedure duration and no blood loss).
Serial lumbar punctures are often performed when the hydrocephalus is communicating. Despite its simplicity, this procedure is associated with increased CSF infections with no evidence of improvement in the rate of shunt placement, disability, and death. 20 Therefore, the implantation of an EVD may represent a suitable and feasible choice for the stepwise management of PHH in ELBW infants with unstable medical conditions. However, even the simple implantation of a standard EVD in such small infants can cause some issues. For example, the dimensions of available catheters do not fit with the dimensions of the infant head. The standard surgical step needed for EVD positioning includes a surgical wound, skull drilling, and a suture, which are risky and dangerously time-consuming for an unstable and delicate patient. Finally, the standard connection with a standard external collection system may lead, in cases of overdrainage, to the risk of brain collapse and intracranial hemorrhage. In cases of underdrainage, there might be CSF leakage due to excessive CSF pressure, which is released through the wound.
Percutaneous-tunneled, transfontanellar external ventricular drainage represents an adaptation of the standard drainage technique intended to minimize the risks for pa- tients: the drain dimensions are adequate to the infant's size, the transfontanellar access makes bone drilling unnecessary, the subcutaneous tunneling and fibrin glue reduce the risk of CSF leakage, and the purely percutaneous technique of implantation allows us to avoid wounds and minimize the duration of surgery. The serial CSF removals produce the same effect as the repeated reservoir tapping without the risks associated with surgical reservoir implantation and the skin damage caused by the repeated transcutaneous reservoir tapping. Another advantage of the small tube dimension is the very low flow rate: the spontaneous CSF withdrawal is slow, gentle, steady, and easily controllable, thus preventing rapid intracranial volume modification. Moreover, the baby can move during CSF removal, and no immobilization is needed. Finally, in comparison with traditional external ventricular drainage, the absence of the CSF line and the external collection system makes nursing the baby in the incubator easier and the ICU setting less demanding for the staff.
Interestingly, the possible catheter obstruction that we expected (as the catheter we used was much thinner than traditional ones), which is especially a factor in the presence of severe IVH, did not occur, and in no case was it necessary to flush the device. In all cases the PTTEVD remained patent for the whole duration of the implantation. We think that the ultrasonography-guided positioning of the catheter (Fig. 3) far from the bigger clot may have contributed to this result.
Another advantage is, in the case of infection, the possibility of immediately starting intrathecal antibiotic therapy, and if no improvement is observed, the PTTEVD can simply be pulled out at bedside (not feasible without another surgery if a previously implanted device such as a reservoir or ventriculosubgaleal shunt is present) simultaneously with the contralateral implantation of another PTTEVD.
The high number of shunting procedures required in the present series could be attributable to the decision to not wait for greater weight gain (which would have otherwise resulted in a greater percentage of shunt-free patients) to reduce the risk of infection. As a matter of fact, if early removal of the catheter is associated with a reduced infection rate, early shunting can be associated with a higher complication rate. 2, 3, 8, 15, 21 Placing a shunt at a patient weight of 1 kg, in our experience, represents an acceptable compromise between the surgical risks and the likelihood of infection with a long-standing PTTEVD. On the other hand, there is probably a greater need for shunts (which will be removed in the future, if possible, by performing a secondary third ventriculostomy). Finally, considering the limited number of studies available on external ventricular drainage in ELBW infants, we believe that future investigations should be aimed at clarifying whether the prolonged use of a PTTEVD is actually related to a higher infection rate and a reduced need for shunting.
Conclusions
When performed in ELBW infants, standard therapeutic procedures for PHH are burdened with high risks that do not easily allow early intervention. The introduction of PTTEVD placement to our standard PHH treatment protocol produced a safe and early bedside option for this delicate subgroup of patients. Although the limited sample size does not allow definitive statements, the features of minimal skin traumatisms, absent blood loss, very short operation times, reversibility at bedside, few and manageable infectious complications, and no CSF leakage make this procedure a valid option in the multistep treatment of PHH in ELBW infants.
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